AI drug discovery startup Converge Bio raised $25 million in a Series A led by Bessemer Venture Partners, with additional backing from executives at Meta, OpenAI, and Wiz.
© 2020-23 Digest Wire. All rights belong to their respective owners.
Tuesday, January 13, 2026
Converge Bio raises $25M, backed by Bessemer and execs from Meta, OpenAI, Wiz
ADVERTISEMENT
Trending
Newcastle v Manchester City: Line-ups, stats and preview
Newcastle take on Manchester City this coming Tuesday in the EFL Cup.
DigestWire is an automated news feed that utilizes AI technology to gather information from sources with varying perspectives. This allows users to gain a comprehensive understanding of different arguments and make informed decisions. DigestWire is dedicated to serving the public interest and upholding democratic values.
Privacy Policy Terms and Conditions